GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Price-to-Funds-From-Operations

AbbVie (WBO:ABBV) Price-to-Funds-From-Operations : (As of May. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is AbbVie Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


AbbVie (WBO:ABBV) Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.